Photoimmunotherapy targeting prostate-specific membrane antigen; Are antibody fragments as effective as antibodies
2015-01-24Prostate cancer affects approximately 200,000 men and account for 30,000 deaths annually i...
In this paper, we propose HIV immunotherapy via arming HIV monoclonal antibodies with photosensitize...
BACKGROUND: There is presently no effective therapy for relapsing, metastatic, androgen-independent ...
Photoimmunotherapy is a highly cell-selective cancer therapy based on an armed antibody conjugate wi...
Photodynamic therapy (PDT) is a promising approach for the treatment of superficially localized tumo...
Prostate carcinoma is the most common non-cutaneous cancer in developed countries and represents the...
Prostate carcinoma is the most common non-cutaneous cancer in developed countries and represents the...
Photodynamic therapy (PDT) is a promising approach for the treatment of superficially localized tumo...
Prostate cancer (PCa) is the most common cancer in men and the second most common cause of cancer-re...
Photodynamic therapy (PDT) is a clinically-approved but rather under-exploited treatment modality fo...
Prostate cancer (PC) is the most common noncutaneous malignancy affecting men in the US, leading to ...
Photosensitizer immunoconjugates (PICs) offer improved photosensitizer delivery specificity and coul...
Purpose of review Targeting Prostate-Specific Membrane Antigen (PSMA) has paved the way for personal...
An isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen (PSMA...
Photodynamic therapy (PDT) utilises light, oxygen and organic macrocycles, called photosensitisers, ...
2015-01-24Prostate cancer affects approximately 200,000 men and account for 30,000 deaths annually i...
In this paper, we propose HIV immunotherapy via arming HIV monoclonal antibodies with photosensitize...
BACKGROUND: There is presently no effective therapy for relapsing, metastatic, androgen-independent ...
Photoimmunotherapy is a highly cell-selective cancer therapy based on an armed antibody conjugate wi...
Photodynamic therapy (PDT) is a promising approach for the treatment of superficially localized tumo...
Prostate carcinoma is the most common non-cutaneous cancer in developed countries and represents the...
Prostate carcinoma is the most common non-cutaneous cancer in developed countries and represents the...
Photodynamic therapy (PDT) is a promising approach for the treatment of superficially localized tumo...
Prostate cancer (PCa) is the most common cancer in men and the second most common cause of cancer-re...
Photodynamic therapy (PDT) is a clinically-approved but rather under-exploited treatment modality fo...
Prostate cancer (PC) is the most common noncutaneous malignancy affecting men in the US, leading to ...
Photosensitizer immunoconjugates (PICs) offer improved photosensitizer delivery specificity and coul...
Purpose of review Targeting Prostate-Specific Membrane Antigen (PSMA) has paved the way for personal...
An isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen (PSMA...
Photodynamic therapy (PDT) utilises light, oxygen and organic macrocycles, called photosensitisers, ...
2015-01-24Prostate cancer affects approximately 200,000 men and account for 30,000 deaths annually i...
In this paper, we propose HIV immunotherapy via arming HIV monoclonal antibodies with photosensitize...
BACKGROUND: There is presently no effective therapy for relapsing, metastatic, androgen-independent ...